Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis

NCT01567358 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Infliximab
BIOLOGICAL: Infliximab

Sponsor

Nichi-Iko Pharmaceutical Co., Ltd.